Skip to main content
Top
Published in: BMC Cancer 1/2016

Open Access 01-12-2016 | Research article

Health professionals and the early detection of head and neck cancers: a population-based study in a high incidence area

Authors: Karine Ligier, Olivier Dejardin, Ludivine Launay, Emmanuel Benoit, Emmanuel Babin, Simona Bara, Bénédicte Lapôtre-Ledoux, Guy Launoy, Anne-Valérie Guizard

Published in: BMC Cancer | Issue 1/2016

Login to get access

Abstract

Background

In the context of early detection of head and neck cancers (HNC), the aim of this study was to describe how people sought medical consultation during the year prior to diagnosis and the impact on the stage of the cancer.

Methods

Patients over 20 years old with a diagnosis of HNC in 2010 were included from four French cancer registries. The medical data were matched with data regarding uptake of healthcare issued from French National Health Insurance General Regime.

Results

In 86.0 % of cases, patients had consulted a general practitioner (GP) and 21.1 % a dentist. Consulting a GP at least once during the year preceding diagnosis was unrelated to Charlson index, age, sex, département, quintile of deprivation of place of residence. Patients from the ‘quite privileged’, ‘quite underprivileged’ and ‘underprivileged’ quintiles consulted a dentist more frequently than those from the ‘very underprivileged’ quintile (p = 0.007).
The stage was less advanced for patients who had consulted a GP (OR = 0.42 [0.18–0.99]) - with a dose–response effect.

Conclusions

In view of the frequency of consultations, the existence of a significant association between consultations and a localised stage at diagnosis and the absence of a socio-economic association, early detection of HNC by GPs would seem to be the most appropriate way.
Literature
1.
go back to reference Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.CrossRefPubMed Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.CrossRefPubMed
2.
go back to reference Ligier K, Belot A, Launoy G, Velten M, Bossard N, Iwaz J, Righini CA, Delafosse P, Guizard AV, network F. Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980-2005 and projection to 2010. Oral Oncol. 2011;47(4):302–7.CrossRefPubMed Ligier K, Belot A, Launoy G, Velten M, Bossard N, Iwaz J, Righini CA, Delafosse P, Guizard AV, network F. Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980-2005 and projection to 2010. Oral Oncol. 2011;47(4):302–7.CrossRefPubMed
3.
go back to reference Ligier K, Plouvier S, Danzon A, Martin P, Benoit E, Molinie F, Launoy G, Buisset E, Leroy X, Chevalier D, et al. Elements of completeness and results of the first year of registration of the “Registre general des cancers de Lille et de sa region”. Rev Epidemiol Sante Publique. 2012;60(2):131–9.CrossRefPubMed Ligier K, Plouvier S, Danzon A, Martin P, Benoit E, Molinie F, Launoy G, Buisset E, Leroy X, Chevalier D, et al. Elements of completeness and results of the first year of registration of the “Registre general des cancers de Lille et de sa region”. Rev Epidemiol Sante Publique. 2012;60(2):131–9.CrossRefPubMed
4.
go back to reference Binder-Foucard F, Belot A, Delafosse P, Remontet L, Woronoff AS, Bossard N: Estimation nationale de l’incidence et de la mortalité par cancer en France entre 1980 et 2012. Partie 1 – Tumeurs solides. Saint-Maurice Institut de veille sanitaire; 2013. http://wwwinvssantefr/Publications-et-outils/Rapports-et-syntheses/Maladies-chroniques-et-traumatismes/2013/Estimation-nationale-de-l-incidence-et-de-la-mortalite-par-cancer-en-France-entre-1980-et-2012. Accessed 6 June 2016. Binder-Foucard F, Belot A, Delafosse P, Remontet L, Woronoff AS, Bossard N: Estimation nationale de l’incidence et de la mortalité par cancer en France entre 1980 et 2012. Partie 1 – Tumeurs solides. Saint-Maurice Institut de veille sanitaire; 2013. http://​wwwinvssantefr/​Publications-et-outils/​Rapports-et-syntheses/​Maladies-chroniques-et-traumatismes/​2013/​Estimation-nationale-de-l-incidence-et-de-la-mortalite-par-cancer-en-France-entre-1980-et-2012.​ Accessed 6 June 2016.
5.
go back to reference Righini CA, Karkas A, Morel N, Soriano E, Reyt E. Risk factors for cancers of the oral cavity, pharynx (cavity excluded) and larynx. Presse Med. 2008;37(9):1229–40.CrossRefPubMed Righini CA, Karkas A, Morel N, Soriano E, Reyt E. Risk factors for cancers of the oral cavity, pharynx (cavity excluded) and larynx. Presse Med. 2008;37(9):1229–40.CrossRefPubMed
6.
go back to reference Menvielle G, Kunst AE, Stirbu I, Strand BH, Borrell C, Regidor E, Leclerc A, Esnaola S, Bopp M, Lundberg O, et al. Educational differences in cancer mortality among women and men: a gender pattern that differs across Europe. Br J Cancer. 2008;98(5):1012–9.CrossRefPubMedPubMedCentral Menvielle G, Kunst AE, Stirbu I, Strand BH, Borrell C, Regidor E, Leclerc A, Esnaola S, Bopp M, Lundberg O, et al. Educational differences in cancer mortality among women and men: a gender pattern that differs across Europe. Br J Cancer. 2008;98(5):1012–9.CrossRefPubMedPubMedCentral
7.
go back to reference Conway DI, Petticrew M, Marlborough H, Berthiller J, Hashibe M, Macpherson LM. Socioeconomic inequalities and oral cancer risk: a systematic review and meta-analysis of case-control studies. Int J Cancer. 2008;122(12):2811–9.CrossRefPubMed Conway DI, Petticrew M, Marlborough H, Berthiller J, Hashibe M, Macpherson LM. Socioeconomic inequalities and oral cancer risk: a systematic review and meta-analysis of case-control studies. Int J Cancer. 2008;122(12):2811–9.CrossRefPubMed
8.
go back to reference Conway DI, Brenner DR, McMahon AD, Macpherson LM, Agudo A, Ahrens W, Bosetti C, Brenner H, Castellsague X, Chen C, et al. Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. Int J Cancer. 2015;136(5):1125–39.CrossRefPubMed Conway DI, Brenner DR, McMahon AD, Macpherson LM, Agudo A, Ahrens W, Bosetti C, Brenner H, Castellsague X, Chen C, et al. Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. Int J Cancer. 2015;136(5):1125–39.CrossRefPubMed
9.
go back to reference Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 2010;15(9):994–1001.CrossRefPubMedPubMedCentral Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 2010;15(9):994–1001.CrossRefPubMedPubMedCentral
10.
go back to reference Saba NF, Goodman M, Ward K, Flowers C, Ramalingam S, Owonikoko T, Chen A, Grist W, Wadsworth T, Beitler JJ, et al. Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis. Oncology. 2011;81(1):12–20.CrossRefPubMedPubMedCentral Saba NF, Goodman M, Ward K, Flowers C, Ramalingam S, Owonikoko T, Chen A, Grist W, Wadsworth T, Beitler JJ, et al. Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis. Oncology. 2011;81(1):12–20.CrossRefPubMedPubMedCentral
11.
go back to reference Cancer registry of Norway. Cancer in Norway 2009. Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer registry of Norway; 2011. Cancer registry of Norway. Cancer in Norway 2009. Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer registry of Norway; 2011.
12.
go back to reference Stefanuto P, Doucet JC, Robertson C. Delays in treatment of oral cancer: a review of the current literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(4):424–9.CrossRefPubMed Stefanuto P, Doucet JC, Robertson C. Delays in treatment of oral cancer: a review of the current literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(4):424–9.CrossRefPubMed
13.
go back to reference Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol. 2007;84(1):5–10.CrossRefPubMed Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol. 2007;84(1):5–10.CrossRefPubMed
14.
go back to reference Waaijer A, Terhaard CH, Dehnad H, Hordijk GJ, van Leeuwen MS, Raaymakers CP, Lagendijk JJ. Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol. 2003;66(3):271–6.CrossRefPubMed Waaijer A, Terhaard CH, Dehnad H, Hordijk GJ, van Leeuwen MS, Raaymakers CP, Lagendijk JJ. Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol. 2003;66(3):271–6.CrossRefPubMed
15.
go back to reference Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, Hamilton W, Hendry A, Hendry M, Lewis R, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112 Suppl 1:S92–S107.CrossRefPubMedPubMedCentral Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, Hamilton W, Hendry A, Hendry M, Lewis R, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112 Suppl 1:S92–S107.CrossRefPubMedPubMedCentral
16.
go back to reference Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2008;87(1):3–16.CrossRefPubMed Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2008;87(1):3–16.CrossRefPubMed
17.
go back to reference Grosclaude P, Remontet L, Belot A, Danzon A, Rasamimanana Cerf N, Bossard N: Survie des personnes atteintes de cancer en France. 1989-2007 - Etude à partir des registres des cancers du réseau Francim. Saint-Maurice Institut de veille sanitaire; 2013. Grosclaude P, Remontet L, Belot A, Danzon A, Rasamimanana Cerf N, Bossard N: Survie des personnes atteintes de cancer en France. 1989-2007 - Etude à partir des registres des cancers du réseau Francim. Saint-Maurice Institut de veille sanitaire; 2013.
18.
go back to reference Zigon G, Berrino F, Gatta G, Sanchez MJ, van Dijk B, Van Eycken E, Francisci S, Group EW. Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study. Ann Onco. 2011;22(1):165–74.CrossRef Zigon G, Berrino F, Gatta G, Sanchez MJ, van Dijk B, Van Eycken E, Francisci S, Group EW. Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study. Ann Onco. 2011;22(1):165–74.CrossRef
19.
go back to reference Babin E, Sigston E, Hitier M, Dehesdin D, Marie JP, Choussy O. Quality of life in head and neck cancers patients: predictive factors, functional and psychosocial outcome. Eur Arch Otorhinolaryngol. 2008;265(3):265–70.CrossRefPubMed Babin E, Sigston E, Hitier M, Dehesdin D, Marie JP, Choussy O. Quality of life in head and neck cancers patients: predictive factors, functional and psychosocial outcome. Eur Arch Otorhinolaryngol. 2008;265(3):265–70.CrossRefPubMed
20.
go back to reference Brocklehurst P, Kujan O, O’Malley LA, Ogden G, Shepherd S, Glenny AM. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev. 2013;11:CD004150.PubMed Brocklehurst P, Kujan O, O’Malley LA, Ogden G, Shepherd S, Glenny AM. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev. 2013;11:CD004150.PubMed
23.
go back to reference Reid BC, Warren JL, Rozier G. Comorbidity and early diagnosis of head and neck cancer in a Medicare population. Am J Prev Med. 2004;27(5):373–8.CrossRefPubMed Reid BC, Warren JL, Rozier G. Comorbidity and early diagnosis of head and neck cancer in a Medicare population. Am J Prev Med. 2004;27(5):373–8.CrossRefPubMed
24.
go back to reference Tromp DM, Brouha XD, Hordijk GJ, Winnubst JA, de Leeuw JR. Patient factors associated with delay in primary care among patients with head and neck carcinoma: a case-series analysis. Fam Pract. 2005;22(5):554–9.CrossRefPubMed Tromp DM, Brouha XD, Hordijk GJ, Winnubst JA, de Leeuw JR. Patient factors associated with delay in primary care among patients with head and neck carcinoma: a case-series analysis. Fam Pract. 2005;22(5):554–9.CrossRefPubMed
25.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
27.
go back to reference Pornet C, Delpierre C, Dejardin O, Grosclaude P, Launay L, Guittet L, Lang T, Launoy G. Construction of an adaptable European transnational ecological deprivation index: the French version. J Epidemiol Community Health. 2012;66(11):982–9.CrossRefPubMedPubMedCentral Pornet C, Delpierre C, Dejardin O, Grosclaude P, Launay L, Guittet L, Lang T, Launoy G. Construction of an adaptable European transnational ecological deprivation index: the French version. J Epidemiol Community Health. 2012;66(11):982–9.CrossRefPubMedPubMedCentral
28.
go back to reference Reid BC, Rozier RG. Continuity of care and early diagnosis of head and neck cancer. Oral Oncol. 2006;42(5):510–6.CrossRefPubMed Reid BC, Rozier RG. Continuity of care and early diagnosis of head and neck cancer. Oral Oncol. 2006;42(5):510–6.CrossRefPubMed
29.
go back to reference Jusot F. Inequalities in access to care and their evolution: a review. Rev Epidemiol Sante Publique. 2013;61 Suppl 3:S163–9.CrossRefPubMed Jusot F. Inequalities in access to care and their evolution: a review. Rev Epidemiol Sante Publique. 2013;61 Suppl 3:S163–9.CrossRefPubMed
30.
go back to reference Dourgnon P, Desprès C, Jusot F, Fantin R. Les comptes de la santé 2010. Série Statistiques – Document de travail de la Drees 2011; 161: 85-96 Dourgnon P, Desprès C, Jusot F, Fantin R. Les comptes de la santé 2010. Série Statistiques – Document de travail de la Drees 2011; 161: 85-96
32.
go back to reference Dionne KR, Warnakulasuriya S, Zain RB, Cheong SC. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int J Cancer. 2015;136(3):503–15.PubMed Dionne KR, Warnakulasuriya S, Zain RB, Cheong SC. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int J Cancer. 2015;136(3):503–15.PubMed
Metadata
Title
Health professionals and the early detection of head and neck cancers: a population-based study in a high incidence area
Authors
Karine Ligier
Olivier Dejardin
Ludivine Launay
Emmanuel Benoit
Emmanuel Babin
Simona Bara
Bénédicte Lapôtre-Ledoux
Guy Launoy
Anne-Valérie Guizard
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2016
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-016-2531-7

Other articles of this Issue 1/2016

BMC Cancer 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine